Sunstone BioSciences, Inc. is a company with cutting-edge optical nanomaterials which are believed to enable breakthrough therapies, diagnostics, and research products.
These products are based on the company's proprietary materials, , which have the exceptional property of energy up-convertion, in that they can transform light from a lower energy to that of higher energy. For example, Sunstone™ Nanoparticles, can be exposed to infrared light and emit visible light in return. Alternatively down-converting Sunstone™ Nanoparticles can convert energy over extremely disparate energy levels, such as transforming x-ray or ultraviolet light into visible or infrared light. These materials can be incorporated into many chemical compositions or drug formulations without losing their optical properties. As a result, they can be utilized in a very large number of applications in which it is desired to convert light energy from one wavelength to another.
The company's world-class Executive Management Team includes individuals with significant experience founding and growing biotechnology and life sciences companies. Our are comprised of scientists and physicians from the University of Pennyslvania, Princeton University, Duke University, and Lehigh University that are thought-leaders in their respective fields.